Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32510 total
Analysts raised price targets across several major tech names on August 12. The moves signal growing confidence after recent earnings beats. CrowdStrike saw its consensus target price tick up to $195.39, from $194.67.…
Insider filings this week reveal a split signal from corporate suites — heavy selling at the top, but at least one prominent CEO is betting big with his own cash. The biggest dump came from ILMN. Board member Keith…
Short sellers are piling into beaten-down names this week. Hertz leads the charge with SI % FF jumping to 69.6% — up 5.3 percentage points in just seven days. The car rental giant has shed 66% over the past three…
China ETFs shed nearly $9.8B in a single week. That is the headline number from this week's ETF flow data — and it marks a sharp reversal from the 3-month trend, where China funds had attracted $20.9B. The U.S. remains…
Semiconductors are driving markets on August 12. NVDA and MU sit atop both the bullish and bearish options flow tables simultaneously. That split signals intense two-way conviction ahead of NVIDIA's next earnings…
Options markets are flashing mixed signals on August 12. Bears and bulls are both placing big bets in semiconductors. NVDA and MU sit at the top of both bullish and bearish options flow lists. That split is rare. It…
POET Technologies reports earnings today with one of the most charged short-side setups in the semiconductor space — more than a fifth of its free float is currently sold short, and the cost to borrow those shares has…
Honeywell Aerospace Inc. heads into its August 14 earnings event carrying the full weight of a brutal Q2 miss — and options traders are more anxious ahead of this print than at any point in the past year. The clearest…
EROC reports its first earnings as a public company today against a backdrop that mixes genuine institutional enthusiasm with a stock that has lost ground since its July debut. The most telling story heading into this…
Churchill Capital Corp XI (CCXI) reports today with the lending market telling a notably different story from just six weeks ago — and a roster of institutional arbitrageurs watching closely. The clearest shift is in…
Maze Therapeutics reports today with a notable divergence at the heart of its setup: short sellers have been adding positions steadily, yet the lending market remains far from stressed — leaving the real tension…
Bitdeer Technologies Group heads into its August 12 earnings event carrying the wreckage of a brutal post-earnings sell-off, with short sellers firmly entrenched and options traders now the most defensively positioned…
BLTE arrives at tomorrow's earnings print on the back of its strongest monthly run in recent memory, with the stock up 19% over the past month and 13% in the last week alone to close at $177.58. The borrow market tells…
Tango Therapeutics reports today against a backdrop that could not be more divided: short sellers control nearly a third of the free float, yet analysts have been aggressively raising targets since June. Short interest…
Erasca reports tonight carrying one of the more loaded short-interest profiles in clinical-stage biotech: roughly 10.7% of the free float is sold short, a level that has been gradually unwinding — down about 1.6% over…
N-able reports Q2 results on August 13 against the most dramatic single-week sell-off the stock has seen in recent memory. The dominant story heading into this print is the price collapse itself. The stock fell nearly…
NPCE reports today with the Street broadly constructive but key questions about profitability still unanswered. Options positioning has tilted more defensive in the run-up to the print. The put/call ratio climbed to…
Analyst desks were busy on August 12, with upgrades, downgrades, and notable target price lifts across several sectors. HRL received the day's standout upgrade. Hormel Foods moved higher in consensus after analysts…
Ouster heads into its August 13 earnings report with a meaningful short position, a stock that has nearly doubled year-to-date, and analysts steadily lifting their targets — a setup that puts real pressure on the…
Immunome heads into its August 13 earnings report with a clear tension: the stock is drifting higher while nearly every insider who can sell, is selling. The insider activity is the standout signal. Over the past 90…
